These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21925307)

  • 41. Label retaining cells in cancer--the dormant root of evil?
    Schillert A; Trumpp A; Sprick MR
    Cancer Lett; 2013 Nov; 341(1):73-9. PubMed ID: 23624300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring a stem cell basis to identify novel treatment for human malignancies.
    Pate SA; Rameshwar P
    J Stem Cells; 2011; 6(4):233-43. PubMed ID: 23550340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence.
    Csermely P; Hódsági J; Korcsmáros T; Módos D; Perez-Lopez ÁR; Szalay K; Veres DV; Lenti K; Wu LY; Zhang XS
    Semin Cancer Biol; 2015 Feb; 30():42-51. PubMed ID: 24412105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of cancer stem cells in vitro.
    Gedye C; Ailles L
    Methods Mol Biol; 2013; 946():181-204. PubMed ID: 23179833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer as a reprogramming-like disease: implications in tumor development and treatment.
    Castellanos A; Vicente-Dueñas C; Campos-Sánchez E; Cruz JJ; García-Criado FJ; García-Cenador MB; Lazo PA; Pérez-Losada J; Sánchez-García I
    Semin Cancer Biol; 2010 Apr; 20(2):93-7. PubMed ID: 20188174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.
    Koren S; Bentires-Alj M
    Mol Cell; 2015 Nov; 60(4):537-46. PubMed ID: 26590713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cells and breast cancer, where we are? A concise review of literature.
    Sanguinetti A; Bistoni G; Avenia N
    G Chir; 2011 Oct; 32(10):438-46. PubMed ID: 22018221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cells in cancer initiation and progression.
    Bajaj J; Diaz E; Reya T
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31874116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem-cell origin of metastasis and heterogeneity in solid tumours.
    Tu SM; Lin SH; Logothetis CJ
    Lancet Oncol; 2002 Aug; 3(8):508-13. PubMed ID: 12147437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cancer cells-of-origin in the gastrointestinal tract: progenitors revisited.
    Lamprecht S; Fich A
    Carcinogenesis; 2015 Aug; 36(8):811-6. PubMed ID: 26116624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogene-induced plasticity and cancer stem cells.
    Rapp UR; Ceteci F; Schreck R
    Cell Cycle; 2008 Jan; 7(1):45-51. PubMed ID: 18196970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Basic stem cell biology and cancer].
    Porse BT; Petersen OW; Helin K
    Ugeskr Laeger; 2010 Sep; 172(38):2600-3. PubMed ID: 20920403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour heterogeneity and cancer cell plasticity.
    Meacham CE; Morrison SJ
    Nature; 2013 Sep; 501(7467):328-37. PubMed ID: 24048065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Origins and clinical implications of the brain tumor stem cell hypothesis.
    Zaidi HA; Kosztowski T; DiMeco F; Quiñones-Hinojosa A
    J Neurooncol; 2009 May; 93(1):49-60. PubMed ID: 19430882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cells: impact, heterogeneity, and uncertainty.
    Magee JA; Piskounova E; Morrison SJ
    Cancer Cell; 2012 Mar; 21(3):283-96. PubMed ID: 22439924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer intra-tumor heterogeneity.
    Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Stem Cell Network model: clinical implications in cancer.
    Cabanillas R; Llorente JL
    Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):161-70. PubMed ID: 18807062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.